Article 04 Jul 2024 Chevron's Demise—And What It Means For Healthcare And Life Sciences Companies United States Healthcare
Article 12 Jun 2024 Loper Bright's Potential Impact On The U.S. Department Of Health And Human Services United States Healthcare
Article 27 May 2024 D.C. Circuit Holds 340B Program Does Not Prohibit Drug Manufacturers From Imposing Contract Pharmacy Restrictions United States Healthcare
Article 16 May 2024 Summary And Key Considerations Of Recent HHS-OIG Advisory Opinion On Pharmaceutical Patient Assistance Program For Rare Disorders United States Healthcare
Article 30 Apr 2024 CMS Proposes Important Enhancements To The New Technology Add-on Payment Program In The FY 2025 IPPS Proposed Rulemaking United States Technology
Article 15 Feb 2024 Gang Of Six Introduces Historic 340B "Discussion Draft" Legislation United States Healthcare
Article 07 Feb 2024 CMS Releases Request For Information On Medicare Advantage Data United States Healthcare
Article 10 Nov 2023 District Court Invalidates 340B Patient Definition In Genesis Case, Raising Questions About Program Scope United States Healthcare
Article 30 Aug 2023 CMS Identifies First 10 Drugs For Medicare Price Negotiation United States Healthcare